Skip to main content
. 2021 Jul 15:10.2217/fon-2021-0121. doi: 10.2217/fon-2021-0121

Table 2. Impact of cancer on COVID-19 outcomes in closed cases.

Characteristics   Discharge p-value Deceased p-value Total p-value
    Noncancer (n = 142) Cancer (n = 42)   Noncancer (n = 33) Cancer (n = 7)   Noncancer (n = 175) Cancer (n = 49)  
Age Mean ± SD 58.0 ± 15.1 63.8 ± 13.2 0.026 61.7 ± 11.3 64.0 ± 12.04 0.64 58.7 ± 14.6 63.6 ± 12.5 0.023
Gender Female 80 (57.1) 20 (47.6) 0.29 15 (46.9) 3 (42.9) 0.84 95 (55.2) 23 (46.9) 0.30
Male 60 (42.9) 22 (52.4)   17 (53.1) 4 (57.1)   77 (44.8) 26 (53.1)  
BMI Mean ± SD 33.3 ± 9.08 31.35 ± 9.3 0.23 36.3 ± 7.66 33.2 ± 8.83 0.34 33.8 ± 8.74 32.1 ± 9.04 0.19
CURB-65 Mean ± SD 1.42 ± 0.73 1.31 ± 0.72 0.38 2.18 ± 1.01 2.00 ± 1.00 0.67 1.59 ± 0.84 1.49 ± 0.85 0.45
qSOFA Mean ± SD 0.67 ± 0.60 0.67 ± 0.69 0.98 1.21 ± 0.82 1.00 ± 1.00 0.55 0.77 ± 0.68 0.70 ± 0.71 0.49
No. comorbidities Mean ± SD 1.04 ± 1.25 2.29 ± 1.13 <0.001 1.24 ± 1.15 2.43 ± 1.51 0.024 1.12 ± 1.27 2.28 ± 1.22 <0.001
ABG P/F ratio 242.7 ± 95 228 ± 137 0.65 139.8 ± 91.9 246.4 ± 118 0.032 208.4 ± 103 203 ± 127 0.83
Laboratory testing CRP 36.0 ± 51.4 29.4 ± 40.4 0.60 35.7 ± 55.7 8.94 ± 5.67 0.30 33.0 ± 50.5 23.5 ± 33.7 0.34
Ferritin 497 ± 423.7 717.5 ± 951 0.33 699.4 ± 439.3 515.8 ± 141.4 0.59 675.4 ± 689 901.4 ± 910 0.29
Procalcitonin 16.6 ± 84.2 0.74 ± 1.37 0.60 60.5 ± 147.7 0.28 ± 0.29 0.52 19.5 ± 86.5 0.64 ± 1.04 0.40
NLR 5.76 ± 3.91 9.32 ± 15.2 0.016 9.33 ± 7.42 5.08 ± 3.37 0.029 8.13 ± 22.3 8.81 ± 13.2 0.83
Require O2 therapy Negative 60 (46.9) 19 (48.7) 0.85 13 (43.3) 2 (28.6) 0.67 73 (46.2) 21 (45.7) 0.94
Positive 68 (53.1) 20 (51.3)   17 (56.7) 5 (71.4)   85 (53.8) 25 (54.3)  
Require intubation Negative 113 (88.3) 34 (87.2) 0.78 7 (23.3) 3 (42.9) 0.36 120 (75.9) 37 (80.4) 0.69
Positive 15 (11.7) 5 (12.8)   23 (76.7) 4 (57.1)   38 (24.1) 9 (19.6)  
Mechanical ventilation Negative 100 (78.1) 30 (76.9) 0.83 6 (20) 4 (57.1) 0.06 106 (67.1) 34 (73.9) 0.47
Positive 28 (21.9) 9 (23.1)   24 (80) 3 (42.9)   52 (32.9) 12 (26.1)  
Extubation Negative 97 (91.5) 29 (87.9) 0.53 21 (75) 5 (71.4) 0.84 118 (88.1) 34 (85) 0.59
Positive 9 (8.5) 4 (12.1)   7 (25) 2 (28.6)   16 (11.9) 6 (15)  
Unplanned reintubation Negative 105 (99.1) 26 (92.9) 0.049 23 (82.1) 4 (80) 0.90 128 (95.5) 30 (90.9) 0.38
Positive 1 (0.9) 2 (7.1)   5 (17.9) 1 (20)   6 (4.5) 3 (9.1)  
ICU admission Floor 97 (77) 28 (71.8) 0.52 4 (13.3) 2 (28.6) 0.31 101 (64.7) 30 (65.2) 0.95
ICU 29 (23) 11 (28.2)   26 (86.7) 5 (71.4)   55 (35.3) 16 (34.8)  
Develop complications Negative 32 (22.9) 10 (24.4) 0.83 3 (9.4) 0 (0) 0.39 35 (20.3) 10 (20.8) 0.94
Positive 108 (77.1) 31 (75.6)   29 (90.6) 7 (100)   137 (79.7) 38 (79.2)  
Type of complications ARDS 26 (18.6) 9 (22) 0.65 14 (43.8) 3 (42.9) 0.96 40 (23.3) 12 (25) 0.84
AKI 30 (21.4) 8 (19.5) 0.79 20 (62.5) 2 (28.6) 0.10 50 (29.1) 10 (20.8) 0.27
Sepsis/shock 22 (15.7) 4 (9.8) 0.45 5 (15.6) 2 (28.6) 0.58 27 (15.7) 6 (12.5) 0.65
LOS Total LOS 8.58 ± 6.50 12.8 ± 11.4 0.002 10.9 ± 6.48 16.5 ± 12.3 0.08 9.49 ± 6.39 14.4 ± 11.4 <0.001
ICU LOS 1.09 ± 2.94 0.89 ± 2.63 0.71 6.88 ± 5.22 4.00 ± 4.65 0.19 2.42 ± 4.30 1.29 ± 3.09 0.09
Ventilation 0.59 ± 2.27 0.84 ± 2.22 0.55 5.50 ± 4.09 3.00 ± 4.00 0.18 1.67 ± 3.44 1.06 ± 2.51 0.26

Data are presented as number (percentage) or mean ± SD. Fisher's exact or chi-square and Mann-Whitney or Student's t-tests were used, blood urea nitrogen level >19 mg/dl (>7 mmol/l), respiratory rate ≥30, blood pressure (systolic <90 mm Hg or diastolic ≤60 mm Hg) and age ≥65 years.

ABG: Arterial blood gases; AKI: Acute kidney injury; ARDS: Acute respiratory distress syndrome; CKD: Chronic kidney disease; COPD: Chronic obstructive pulmonary disease; CRP: C-reactive protein; CURB-65: Confusion status; CVD: Cerebrovascular disease; ICU: Intensive care unit; LOS: length of stay; NLR: Neutrophil-to-lymphocyte ratio; P/F ratio: PaO2/FiO2 ratio of arterial oxygen partial pressure (PaO2 in mmHg) to fractional inspired oxygen (FiO2 expressed as a fraction); qSOFA: Quick Sequential Organ Failure Assessment; SD: Standard deviation.